Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Proinflammatory S100A12 can activate human monocytes via Toll-like receptor 4.

Foell D, Wittkowski H, Kessel C, Lüken A, Weinhage T, Varga G, Vogl T, Wirth T, Viemann D, Björk P, van Zoelen MA, Gohar F, Srikrishna G, Kraft M, Roth J.

Am J Respir Crit Care Med. 2013 Jun 15;187(12):1324-34. doi: 10.1164/rccm.201209-1602OC.

PMID:
23611140
2.

Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease.

Foell D, Wittkowski H, Ren Z, Turton J, Pang G, Daebritz J, Ehrchen J, Heidemann J, Borody T, Roth J, Clancy R.

J Pathol. 2008 Oct;216(2):183-92. doi: 10.1002/path.2394.

PMID:
18729068
4.

Neutrophil-derived S100A12 in acute lung injury and respiratory distress syndrome.

Wittkowski H, Sturrock A, van Zoelen MA, Viemann D, van der Poll T, Hoidal JR, Roth J, Foell D.

Crit Care Med. 2007 May;35(5):1369-75.

PMID:
17414728
5.

S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules.

Foell D, Wittkowski H, Vogl T, Roth J.

J Leukoc Biol. 2007 Jan;81(1):28-37. Epub 2006 Aug 30. Review.

PMID:
16943388
6.

Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12.

Wittkowski H, Hirono K, Ichida F, Vogl T, Ye F, Yanlin X, Saito K, Uese K, Miyawaki T, Viemann D, Roth J, Foell D.

Arthritis Rheum. 2007 Dec;56(12):4174-81.

7.
8.

B7-H3 augments the inflammatory response and is associated with human sepsis.

Zhang G, Wang J, Kelly J, Gu G, Hou J, Zhou Y, Redmond HP, Wang JH, Zhang X.

J Immunol. 2010 Sep 15;185(6):3677-84. doi: 10.4049/jimmunol.0904020. Epub 2010 Aug 9.

9.

Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease.

Foell D, Kucharzik T, Kraft M, Vogl T, Sorg C, Domschke W, Roth J.

Gut. 2003 Jun;52(6):847-53.

10.

S100A12 and soluble receptor for advanced glycation end products levels during human severe sepsis.

Achouiti A, Föll D, Vogl T, van Till JW, Laterre PF, Dugernier T, Wittebole X, Boermeester MA, Roth J, van der Poll T, van Zoelen MA.

Shock. 2013 Sep;40(3):188-94. doi: 10.1097/SHK.0b013e31829fbc38.

PMID:
23846410
11.

Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens.

Skinner NA, MacIsaac CM, Hamilton JA, Visvanathan K.

Clin Exp Immunol. 2005 Aug;141(2):270-8.

12.

Scavenger receptors are associated with cellular interactions of S100A12 in vitro and in vivo.

Hoppmann S, Steinbach J, Pietzsch J.

Int J Biochem Cell Biol. 2010 May;42(5):651-61. doi: 10.1016/j.biocel.2009.12.010. Epub 2009 Dec 16.

PMID:
20025991
13.

S100A12 provokes mast cell activation: a potential amplification pathway in asthma and innate immunity.

Yang Z, Yan WX, Cai H, Tedla N, Armishaw C, Di Girolamo N, Wang HW, Hampartzoumian T, Simpson JL, Gibson PG, Hunt J, Hart P, Hughes JM, Perry MA, Alewood PF, Geczy CL.

J Allergy Clin Immunol. 2007 Jan;119(1):106-14. Epub 2006 Oct 6.

PMID:
17208591
14.

Effect of circulating soluble receptor for advanced glycation end products (sRAGE) and the proinflammatory RAGE ligand (EN-RAGE, S100A12) on mortality in hemodialysis patients.

Nakashima A, Carrero JJ, Qureshi AR, Miyamoto T, Anderstam B, Bárány P, Heimbürger O, Stenvinkel P, Lindholm B.

Clin J Am Soc Nephrol. 2010 Dec;5(12):2213-9. doi: 10.2215/CJN.03360410. Epub 2010 Sep 16.

15.

Olopatadine suppresses the migration of THP-1 monocytes induced by S100A12 protein.

Kishimoto K, Kaneko S, Ohmori K, Tamura T, Hasegawa K.

Mediators Inflamm. 2006;2006(1):42726.

16.

Plasma S100A12 concentrations in peritoneal dialysis patients and subclinical chronic inflammatory disease.

Uchiyama-Tanaka Y, Mori Y, Kosaki A, Kimura T, Moriishi M, Kawanishi H, Matsubara H.

Ther Apher Dial. 2008 Feb;12(1):28-32. doi: 10.1111/j.1744-9987.2007.00537.x.

PMID:
18257809
17.

Up-regulation of MyD88s and SIGIRR, molecules inhibiting Toll-like receptor signaling, in monocytes from septic patients.

Adib-Conquy M, Adrie C, Fitting C, Gattolliat O, Beyaert R, Cavaillon JM.

Crit Care Med. 2006 Sep;34(9):2377-85.

PMID:
16850005
18.

Expression of toll-like receptors in neonatal sepsis.

Viemann D, Dubbel G, Schleifenbaum S, Harms E, Sorg C, Roth J.

Pediatr Res. 2005 Oct;58(4):654-9.

PMID:
16189189
19.

Human S100A12: a novel key player in inflammation?

Pietzsch J, Hoppmann S.

Amino Acids. 2009 Mar;36(3):381-9. doi: 10.1007/s00726-008-0097-7. Epub 2008 Apr 29. Review.

PMID:
18443896
20.

Serum S100A12 (EN-RAGE) levels in patients with decreased renal function and subclinical chronic inflammatory disease.

Zakiyanov O, Kalousová M, Kříha V, Zima T, Tesař V.

Kidney Blood Press Res. 2011;34(6):457-64. doi: 10.1159/000329291. Epub 2011 Aug 5.

Supplemental Content

Support Center